A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...

The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA ...

Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the US market.

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

Zydus receives US FDA tentative approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:05 Hrs [IST] Zydus Lifesciences Limited has ...

If approved by the FDA, the pill could offer an easier alternative than injected cholesterol-lowering medicines.

A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...

Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...

Zydus Lifesciences has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for diabetes drug Dapagliflozin Tablets, 5 mg and 10 mg, a generic of AstraZeneca ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Stockholm, Sweden, February 4, 2026. Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm: EGTX), today noted that the U.S. Food and Drug Administration's (FDA's) Rare Pediatric ...

Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early ...